Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
VHH WE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EW
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH VE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EV
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EEE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH W
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH V
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH U
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH E
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
RBD nanoparticle vaccine
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/12/2021
Obatoclax
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/11/2021
(S)-3-((S)-3-(4-methoxyphenyl)-2-((S)-2-(2-morpholinoacetamido)propanamido) propanamido)-2-oxo-N,4-diphenylbutanamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/10/2021
AT-511
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
W25
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
S-FL-opt/S1 recombinant protein
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/08/2021
12f
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021
S-8510
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
(2s,3r)-2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-2,3-dihydro-4h-chromen-4-one
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021
ZINC104875569
Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021